We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Newborns Getting Preoperative Blood Transfusions Have More Complications

By LabMedica International staff writers
Posted on 05 Nov 2020
Blood transfusions in the neonatal patient population are common, but there are no established guidelines regarding transfusion thresholds. More...
Little is known about postoperative outcomes in neonates who receive preoperative blood transfusions (PBTs).

Transfusion practices in neonatal intensive care units (ICUs) remain highly variable despite several randomized trials showing no harm with a restrictive transfusion strategy in babies compared with a liberal one. It's not uncommon for anemic newborns to receive transfusions prior to surgery as a precaution.

Medical scientists at the Alfred I. duPont Hospital for Children (Wilmington, DE, USA) and their colleagues identified a total of 12,184 neonates, of whom 1,209 (9.9%) received a PBT, all neonates who underwent surgery. Mortality and composite morbidity (defined as any postoperative complication) in neonates who received a PBT within 48 hours of surgery were compared with that in neonates who did not receive a transfusion.

The team reported that the incidence of 30-day mortality (16.8% versus 2.6%) and morbidity (46.2% versus 16.2%) put neonates who received blood transfusion within 48 hours of surgery at a disadvantage compared with peers not getting transfusion. Blood transfusion remained associated with worse postoperative outcomes after multivariable adjustment and propensity-score matching.

Specific postoperative complications that occurred more frequently in the transfusion group included infection, bleeding requiring transfusion, reintubation, reoperation, and hospital stay beyond 30 days. However, babies who did not receive transfusion had more readmissions within 30 days of surgery. There appeared to be a stronger relationship between mortality and morbidity and blood transfusion with rising preoperative hematocrit (up to 35%), though this finding did not reach statistical significance for interaction.

The authors concluded that it is likely that there is a tipping point or range in which the risks associated with anemia outweigh the risks associated with blood transfusion. For infants with significant anemia, it is plausible that the benefits of a blood transfusion, such as increased oxygen delivery, outweigh the associated risks (i.e., transfusion-related immunomodulation and a proinflammatory state), but as the anemia becomes less severe, the harm of a blood transfusion begins to outweigh the benefit. The study was published on October 1, 2020 in the journal Pediatrics.

Related Links:
Alfred I. duPont Hospital for Children


New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study shows that periodic ctDNA screening after surgery can help guide a decision to begin adjuvant immunotherapy (Photo courtesy of Adobe Stock)

Blood Test Guides Post-Surgical Immunotherapy for Muscle-Invasive Bladder Cancer

After surgery for muscle-invasive bladder cancer, many patients face uncertainty about whether residual cancer cells remain in their bodies. Now, a new international phase 3 study has demonstrated that... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.